©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 1880-1895
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.1880
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.1880
| Guidelines | Management |
| IAP (2006) | Indications: Surgery |
| AGA (2015) | Indications: Surgery |
| IAP (2017) | High risk stigmata: Surgery |
| Worrisome features: Surgery versus close surveillance based on: Patients’ age/comorbidities: More aggressive management (surgery) in young patients | |
| EUS findings: Surgery indicated in clear MPD involvement and/or high-risk features | |
| European (2018) | Absolute indications: Surgery |
| Relative indications: Surgery according to criteria count, depending on comorbidities | |
| In fit patients: surgery for 1 criterion | |
| In patients with significant comorbidities: surgery for 2 criteria |
- Citation: Jabłońska B, Szmigiel P, Mrowiec S. Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management. World J Gastrointest Oncol 2021; 13(12): 1880-1895
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/1880.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.1880